Coherus BioSciences Inc - Coherus-Junshi Collaboration Announcement Webcast and Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Coherus BioSciences, Inc. conference call. (Operator Instructions) I would now like to hand the conference over to your first speaker for today, Mr. McDavid Stilwell. Please go ahead.
Thank you, operator. Good morning, everyone, and thank you for joining us. We issued a press release earlier announcing our collaboration with Junshi BioSciences. This release can be found on the Coherus BioSciences website.
Today's call includes forward-looking statements regarding Coherus' current expectations. These statements include, but are not limited to, statements relating to our collaboration with Junshi BioSciences, the stock purchase agreement between Coherus and Junshi BioSciences, our co-development of toripalimab monotherapy and combinations, our ability to successfully register toripalimab in the United States and Canada, our ability to successfully commercialize toripalimab and other
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |